Cite
Scapa E, Thomas P, Loewenstein MS, et al. Serum beta-N-acetyl hexosaminidase (beta-NAH) as a discriminant between malignant and benign extrahepatic biliary obstruction: comparison with carcinoembryonic antigen (CEA). Eur J Cancer Clin Oncol. 1985;21(9):1037-42doi: 10.1016/0277-5379(85)90287-1.
Scapa, E., Thomas, P., Loewenstein, M. S., & Zamcheck, N. (1985). Serum beta-N-acetyl hexosaminidase (beta-NAH) as a discriminant between malignant and benign extrahepatic biliary obstruction: comparison with carcinoembryonic antigen (CEA). European journal of cancer & clinical oncology, 21(9), 1037-42. https://doi.org/10.1016/0277-5379(85)90287-1
Scapa, E, et al. "Serum beta-N-acetyl hexosaminidase (beta-NAH) as a discriminant between malignant and benign extrahepatic biliary obstruction: comparison with carcinoembryonic antigen (CEA)." European journal of cancer & clinical oncology vol. 21,9 (1985): 1037-42. doi: https://doi.org/10.1016/0277-5379(85)90287-1
Scapa E, Thomas P, Loewenstein MS, Zamcheck N. Serum beta-N-acetyl hexosaminidase (beta-NAH) as a discriminant between malignant and benign extrahepatic biliary obstruction: comparison with carcinoembryonic antigen (CEA). Eur J Cancer Clin Oncol. 1985 Sep;21(9):1037-42. doi: 10.1016/0277-5379(85)90287-1. PMID: 2933260.
Copy
Download .nbib